Download PDF

Other users also viewed these articles

The clinical utility of faecal calprotectin in patients with differentiated and undifferentiated spondyloarthritis: Relevance and clinical implications Yasser Emad; Yasser Ragab; Nevin Hammam; Nashwa El-Shaarawy; Magdy Fawzi; Arwa Amer; Hesham El-Makhzangy; Ahmed Ismail; Ossama Ibrahim; Yosra Hassan; Ahmed Kamal; Johannes J. Rasker;
Reumatol Clin. 2022;18:69-76
2021 clinical practice guidelines for the diagnosis, treatment, and follow-up of patients with peripheral spondyloarthritis. Colombian Association of Rheumatology Lina M. Saldarriaga-Rivera; Wilson Bautista-Molano; Alejandro Junca-Ramírez; Andrés R. Fernández-Aldana; Daniel G. Fernández-Ávila; Diego A. Jaimes; Edwin A. Jáuregui; Juan S. Segura-Charry; Consuelo Romero-Sánchez; Oscar J. Felipe-Diaz;
Reumatol Clin. 2022;18:5-14
Epidemiological characteristics and adverse events of patients with psoriatic arthritis undergoing treatment with biological therapies in Galicia Carlos García Porrúa; Francisco José Maceiras Pan; José Antonio Mosquera Martínez; Loreto Carmona; Blanca Correa Rey; Luis Fernández Domínguez; María Noelia Álvarez Rivas; José Antonio Pinto Tasende;
Reumatol Clin. 2021;17:150-4